Sandoz Debuts Denosumab Duo In Canada
Company Claims First Canadian Launch Of Biosimilar Rivals To Prolia And Xgeva
Executive Summary
Sandoz has delivered the first denosumab biosimilar launch in Canada, introducing its Jubbonti and Wyost rivals to Amgen’s Prolia and Xgeva.